Gene · 9356
Papers1,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Use of Cheminformatics to Determine Potential Drug Interactions between Popular Barbadian Botanical Medicines and Antihypertensive Drugs. | ACS Omega | 2022 | 36530331 | PubTator, text mining | PubMed |
| Drug-induced liver injury in COVID-19 treatment: Incidence, mechanisms and clinical management. | Front Pharmacol | 2022 | 36518661 | PubTator, text mining | PubMed |
| Estimated Kidney Tubular Secretion and Kidney, Cardiovascular, and Mortality Outcomes in CKD: The Systolic Blood Pressure Intervention Trial. | Kidney Med | 2022 | 36507053 | PubTator, text mining | PubMed |
| Acetylsalicylic Acid-Primus Inter Pares in Pharmacology. | Molecules | 2022 | 36500502 | PubTator, text mining | PubMed |
| New insight into the management of renal excretion and hyperuricemia: Potential therapeutic strategies with natural bioactive compounds. | Front Pharmacol | 2022 | 36483739 | PubTator, text mining | PubMed |
| Development and validation of an LC-MS/MS method to quantify kynurenic acid in human plasma. | Bioanalysis | 2022 | 36473019 | PubTator, text mining | PubMed |
| Methylation differences in Alzheimer's disease neuropathologic change in the aged human brain. | Acta Neuropathol Commun | 2022 | 36447297 | PubTator, text mining | PubMed |
| Involvement of Transporters in Intestinal Drug-Drug Interactions of Oral Targeted Anticancer Drugs Assessed by Changes in Drug Absorption Time. | Pharmaceutics | 2022 | 36432682 | PubTator, text mining | PubMed |
| Altered Serum Uric Acid Levels in Kidney Disorders. | Life (Basel) | 2022 | 36431026 | PubTator, text mining | PubMed |
| Shared 6mer Peptides of Human and Omicron (21K and 21L) at SARS-CoV-2 Mutation Sites. | Antibodies (Basel) | 2022 | 36412834 | PubTator, text mining | PubMed |
| Effects of polysaccharides-riched Prunus mume fruit juice concentrate on uric acid excretion and gut microbiota in mice with adenine-induced chronic kidney disease. | Curr Res Food Sci | 2022 | 36387593 | PubTator, text mining | PubMed |
| Assessment of potential drug-drug interactions among outpatients in a tertiary care hospital: focusing on the role of P-glycoprotein and CYP3A4 (retrospective observational study). | Heliyon | 2022 | 36387483 | PubTator, text mining | PubMed |
Pharmacokinetic herb-drug interactions: Altered systemic exposure and tissue distribution of ciprofloxacin, a substrate of multiple transporters, after combined treatment with Polygonum capitatum Buch.-Ham. ex D. Don extracts. | Front Pharmacol | 2022 | 36386188 | PubTator, text mining | PubMed |
| A human kidney and liver organoid-based multi-organ-on-a-chip model to study the therapeutic effects and biodistribution of mesenchymal stromal cell-derived extracellular vesicles. | J Extracell Vesicles | 2022 | 36382606 | PubTator, text mining | PubMed |
| Decreasing microbiota-derived uremic toxins to improve CKD outcomes. | Clin Kidney J | 2022 | 36381370 | PubTator, text mining | PubMed |
| Pharmacokinetic considerations to optimize clinical outcomes for COVID-19 drugs. | Trends Pharmacol Sci | 2022 | 36374805 | PubTator, text mining | PubMed |
| Feasibility of a Pragmatic PBPK Modeling Approach: Towards Model-Informed Dosing in Pediatric Clinical Care. | Clin Pharmacokinet | 2022 | 36369327 | PubTator, text mining | PubMed |
| Construction and Evaluation of a Novel Organic Anion Transporter 1/3 CRISPR/Cas9 Double-Knockout Rat Model. | Pharmaceutics | 2022 | 36365126 | PubTator, text mining | PubMed |
| Anti-Inflammatory and Hypouricemic Effect of Bioactive Compounds: Molecular Evidence and Potential Application in the Management of Gout. | Curr Issues Mol Biol | 2022 | 36354664 | PubTator, text mining | PubMed |
| Structural basis of organic cation transporter-3 inhibition. | Nat Commun | 2022 | 36344565 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9356/papers?page=16